🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Study of CM313(SC) Injection in Subjects With Platelet Transfusion Refractoriness

RecruitingPhase 1, Phase 2Ages 18 Years - anyAllKeymed Biosciences Co.Ltd
NCT06792019 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This is a randomized, open-label, phase IB/II clinical study to evaluate the safety and preliminary efficacy of CM313(SC) injection in patients with Platelet Transfusion Refractoriness.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Thrombocytopenia dependent on platelet transfusions and diagnosed with platelet transfusion refractoriness. 2. Presence of one or more kinds of antiplatelet antibodies. 3. Male or female, age≥18 years. 4. The Eastern Cooperative Oncology Group (ECOG) physical status score ≤2. 5. Willing and able to comply with the requirements for this study and written informed consent. Exclusion Criteria: 1. Diagnosed with Idiopathic thrombocytopenic purpura. 2. Platelet transfusion refractoriness caused by non-immune factors. 3. Previously treated with the anti-CD38 monoclonal antibody. 4. Have an allergy to humanized monoclonal antibody or any part of CM313. 5. Pregnant or breastfeeding females, or females planning to become pregnant during the study. 6. Any condition considered to be ineligible for the study by the investigator.
💊

What it tests

  • CM313(SC) injection-low dose
  • CM313(SC) injection-high dose
📍

Where

1 site
Institute of Hematology & Blood Diseases Hospital
Tianjin, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy